Literature DB >> 1673793

Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

W C Nichols1, S E Lyons, J S Harrison, R L Cody, D Ginsburg.   

Abstract

von Willebrand disease (vWD), the most common inherited bleeding disorder in humans, results from abnormalities in the plasma clotting protein von Willebrand factor (vWF). Severe (type III) vWD is autosomal recessive in inheritance and is associated with extremely low or undetectable vWF levels. We report a method designed to distinguish mRNA expression from the two vWF alleles by PCR analysis of peripheral blood platelet RNA using DNA sequence polymorphisms located within exons of the vWF gene. This approach was applied to a severe-vWD pedigree in which three of eight siblings are affected and the parents and additional siblings are clinically normal. Each parent was shown to carry a vWF allele that is silent at the mRNA level. Family members inheriting both abnormal alleles are affected with severe vWD, whereas individuals with only one abnormal allele are asymptomatic. The maternal and paternal silent alleles are identical at two coding sequence polymorphisms as well as an intron 40 variable number tandem repeat, suggesting a possible common origin. Given the frequencies of the two exon polymorphisms reported here, this analysis should be applicable to approximately 70% of type I and type III vWD patients. This comparative DNA and RNA PCR-restriction fragment length polymorphism approach may also prove useful in identifying defects at the level of gene expression associated with other genetic disorders.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673793      PMCID: PMC51552          DOI: 10.1073/pnas.88.9.3857

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification.

Authors:  H Okayama; D T Curiel; M L Brantly; M D Holmes; R G Crystal
Journal:  J Lab Clin Med       Date:  1989-08

2.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  A relatively high frequency of severe (type III) von Willebrand's disease in Israel.

Authors:  S A Berliner; U Seligsohn; A Zivelin; E Zwang; G Sofferman
Journal:  Br J Haematol       Date:  1986-03       Impact factor: 6.998

4.  Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.

Authors:  B R Bahnak; J M Lavergne; C L Verweij; C Rothschild; H Pannekoek; M J Larrieu; D Meyer
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

5.  Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease.

Authors:  Y Sultan; J Simeon; J P Caen
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

6.  Inheritance and prevalence of von Willebrand's disease severe form in a Brazilian population.

Authors:  R R Fischer; C Lerner; E Bandinelli; A S Fonseca; I Roisenberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

8.  von Willebrand disease investigated by two novel RFLPs.

Authors:  F Bernardi; S Guerra; P Patracchini; S Volinia; D Buzzoni; G Ballerini; A Casonato; G Marchetti
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

9.  Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.

Authors:  C L Verweij; R Quadt; E Briët; K Dubbeldam; G B van Ommen; H Pannekoek
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

10.  Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.

Authors:  K Y Ngo; V T Glotz; J A Koziol; D C Lynch; J Gitschier; P Ranieri; N Ciavarella; Z M Ruggeri; T S Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more
  9 in total

1.  Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.

Authors:  W C Nichols; U Seligsohn; A Zivelin; V H Terry; N D Arnold; D R Siemieniak; R J Kaufman; D Ginsburg
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage.

Authors:  Paula M Jacobi; Joan Cox Gill; Veronica H Flood; David A Jakab; Kenneth D Friedman; Sandra L Haberichter
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

3.  Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region.

Authors:  W S Watkins; R Zenger; E O'Brien; D Nyman; A W Eriksson; M Renlund; L B Jorde
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

4.  Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.

Authors:  Jordan A Shavit; Ani Manichaikul; Heidi L Lemmerhirt; Karl W Broman; David Ginsburg
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

5.  Multiplex PCR and quality control of Epinotia aporema granulovirus production.

Authors:  Maria Alejandra Manzán; Ernesto Mario Aljinovic; Marina Elizabeth Biedma; Alicia Sciocco-Cap; Pablo Daniel Ghiringhelli; Víctor Romanowski
Journal:  Virus Genes       Date:  2008-07-15       Impact factor: 2.332

6.  Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

Authors:  Z P Zhang; M Lindstedt; G Falk; M Blombäck; N Egberg; M Anvret
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

7.  A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.

Authors:  V Siguret; J M Lavergne; G Chérel; C Boyer-Neumann; A S Ribba; B R Bahnak; D Meyer; G Piétu
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

Review 8.  Nonsense-mediated mRNA decay among coagulation factor genes.

Authors:  Shirin Shahbazi
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

9.  Family-specific degenerate primer design: a tool to design consensus degenerated oligonucleotides.

Authors:  Javier Alonso Iserte; Betina Ines Stephan; Sandra Elizabeth Goñi; Cristina Silvia Borio; Pablo Daniel Ghiringhelli; Mario Enrique Lozano
Journal:  Biotechnol Res Int       Date:  2013-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.